PRP Monotherapy Reprograms the Chemo-resistant State

PRP Monotherapy Reprograms the Chemoresistant State

PRP Monotherapy Reprograms the Chemo-resistant State and Enhances Chemotherapeutic Response in Pancreatic Cancer

Format

JPEG

Source

Propanc Biopharma, Inc.

Téléchargements